Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 26 (4) , 730-737
- https://doi.org/10.1097/00003246-199804000-00024
Abstract
To evaluate the effect of hemofilter pore size on the efficacy of continuous arteriovenous hemofiltration (CAVH) in improving morbidity and mortality in an immature swine model of Staphylococcus aureus-induced septicemia. Prospective, randomized study with age-matched controls. Biomedical research facility. Fourteen 4 to 8-wk-old, weaned Poland-China swine, weighing 5 to 10 kg. Spontaneously breathing, ketamine-sedated swine (4 to 8 wks of age) were given an intravenous lethal dose of live S. aureus. Animals were then filtered with either a 50-kilodalton (kD) pore size filter (control) or a 100-kD pore size filter (experimental). No animals received antibiotics. Physiologic, biochemical, and hematologic parameters were measured in all animals every 1 to 3 hrs. Animals were monitored continuously and survival time (hr) was recorded (permanent survival = 168 hrs/7 days). Animals filtered with the 100-kD filter survived significantly longer than control animals (103 +/- 18 [SEM] vs. 56 +/- 9 hrs). The 100-kD-filtered group had one permanent survivor (168 hrs). Protein concentration of the ultrafiltrate obtained from the 100-kD-filtered animals was eight-fold higher than control ultrafiltrate. The protein removed did not contain a high percentage of albumin (as determined by autoanalyzer methods). No significant differences were seen in any of the other measured parameters. CAVH significantly improved survival in swine with S. aureus-induced sepsis. The superior performance of the 100-kD filter vs. the 50-kD filter suggests that higher molecular weight mediators that are not removed efficiently by the 50-kD filter may be responsible for the morbidity and mortality seen in this model of sepsis. These mediators may be removed in greater proportion by our customized (100-kD pore size) filter. (Crit Care Med 1998; 26:730-737)Keywords
This publication has 12 references indexed in Scilit:
- Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusionThe Annals of Thoracic Surgery, 1996
- Hemofiltration during Cardiopulmonary Bypass in Pediatric Cardiac SurgeryAnesthesiology, 1994
- Cytokine production and hemofiltration in children undergoing cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swineCritical Care Medicine, 1993
- Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patientsCritical Care Medicine, 1989
- Hemofiltration in septic ards. the artificial kidney as, an artificial endocrine lungResuscitation, 1986
- Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shockCritical Care Medicine, 1985
- Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsisCritical Care Medicine, 1984
- Continuous Arteriovenous Hemofiltration in the Critically Ill PatientAnnals of Internal Medicine, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976